Tumor tissues from ICB nonresponders exhibited higher levels of both tumoral USP22 and EZH2 expression and lower tumoral β2M expression when compared with biopsies from patients who were ICB responsive (Figure 6, A and D). The gene discussed is USP22; the disease is neoplasm.